1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis highlighted topic encourages investigator-initiated applications focused on acquired neuropathy (AN), including chemotherapy-induced peripheral neuropathy (CIPN).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Researchers at institutions, typically requiring a Ph. D. , M. D. , or equivalent professional degree. Apply through an appropriate NIH Parent Funding Announcement or another broad NIH opportunity available on Grants. Confirm the full requirements in the official notice before applying.
Applications for Advancing Toward a Cure for Acquired Neuropathy are due April 6, 2028. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Advancing Toward a Cure for Acquired Neuropathy is funded by National Cancer Institute (NCI) / National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
NIH SBIR/STTR Parent SBIR (R43/R44) Clinical Trial Not Allowed (PA-24-245) is sponsored by National Institutes of Health (NIH). The NIH SBIR program supports small businesses developing innovative technologies that address health-related challenges through Phase I and Phase II funding, focusing on establishing technical feasibility, research and development, and advancing toward commercialization.
REARM Special Call: Robotic Enhancements for Armaments Manufacturing is sponsored by NextFlex (administered on behalf of the Department of Defense). This competitive funding opportunity seeks projects that develop, demonstrate, and transition advanced manufacturing capabilities to accelerate the modernization of the U.S. Munitions Industrial Base (MIB), with a focus on robotic enhancements for armaments manufacturing.
PAR-27-062 creates a three-year, $80,000-salary postdoctoral career award across NCI, NIAID, NIBIB, NIDCR and NINDS — and it carries a hard eligibility window that closes two years after you start your postdoc. Full analysis of the Academic Career Excellence Award, what it replaces, and why the timing rule is the whole competition.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article